logo
Select company
Select metric
Ticker Information

Ticker

CNTB

Company Name

CONNECT BIOPHARMA HOLDINGS LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CONNECT BIOPHARMA HOLDINGS LTD - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CNTB - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ 0$ 0155.5M
3/31/2025$ 0$ 0155.35M
12/31/2024$ -14.74M$ -0.27155.21M
6/30/2024$ 0$ 0155.14M
12/31/2023$ -59.36M$ -1.08155.1M
6/30/2023$ 0$ 0155.04M
12/31/2022$ -108.9M$ -1.98155.04M
6/30/2022$ 0$ 0157.42M
12/31/2021$ -178.8M$ -3.25155.08M
6/30/2021$ 0$ 0157.48M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CONNECT BIOPHARMA HOLDINGS LTD's latest trailing twelve months (TTM) EBITDAPS stands at $ -1.97.
  • Over the past 5 years, CONNECT BIOPHARMA HOLDINGS LTD's average EBITDAPS has been $ -1.71.
  • The median EBITDAPS for CONNECT BIOPHARMA HOLDINGS LTD during this period was $ -1.97
  • CONNECT BIOPHARMA HOLDINGS LTD reached its highest EBITDAPS over the past 5 years at $ -0.27.
  • The lowest EBITDAPS recorded by CONNECT BIOPHARMA HOLDINGS LTD in the same timeframe $ -3.25

CONNECT BIOPHARMA HOLDINGS LTD's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
ORMP : ORAMED PHARMACEUTICALS INC $ -0.84OTLK : OUTLOOK THERAPEUTICS INC $ -1.17OBIO : ORCHESTRA BIOMED HOLDINGS INC $ -1.79NTRB : NUTRIBAND INC $ -0.89BTAI : BIOXCEL THERAPEUTICS INC $ -4.41AVR : ANTERIS TECHNOLOGIES GLOBAL CORP -PYXS : PYXIS ONCOLOGY INC $ -1.53AVTX : AVALO THERAPEUTICS INC $ -4.42DTIL : PRECISION BIOSCIENCES INC $ -6.67LGVN : LONGEVERON INC $ -1.16

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for CONNECT BIOPHARMA HOLDINGS LTD is calculated as follows: EBITDA [ $ -106.36M ] / (Shares WA [ 53.94M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -1.97 ]

CNTB - EBITDA per Share, Last 5 years

$ -3.25

Minimum

Dec 31, 2021

$ -0.27

Maximum

Dec 31, 2024

$ -1.71

Average

$ -1.97

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28